Geneos Wealth Management’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-10,087
| Closed | -$107K | – | 1992 |
|
|
2022
Q2 | $107K | Hold |
10,087
| – | – | 0.01% | 987 |
|
|
2022
Q1 | $98K | Sell |
10,087
-200
| -2% | -$1.94K | ﹤0.01% | 1102 |
|
|
2021
Q4 | $147K | Sell |
10,287
-50
| -0.5% | -$714 | 0.01% | 1007 |
|
|
2021
Q3 | $177K | Buy |
10,337
+1,997
| +24% | +$34.2K | 0.01% | 912 |
|
|
2021
Q2 | $170K | Buy |
8,340
+250
| +3% | +$5.1K | 0.01% | 918 |
|
|
2021
Q1 | $215K | Sell |
8,090
-12,620
| -61% | -$335K | 0.01% | 934 |
|
|
2020
Q4 | $560K | Buy |
+20,710
| New | +$560K | 0.02% | 512 |
|